Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Recruiting Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0088305 (Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02567422M6620, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaTreatment